Opaleye Management’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-653,000
| Closed | -$1.06M | – | 49 |
|
|
2023
Q2 | $1.06M | Hold |
653,000
| – | – | 0.25% | 41 |
|
|
2023
Q1 | $1.39M | Sell |
653,000
-807,000
| -55% | -$1.72M | 0.42% | 39 |
|
|
2022
Q4 | $5.4M | Sell |
1,460,000
-1,655,000
| -53% | -$6.12M | 1.88% | 17 |
|
|
2022
Q3 | $2.32M | Buy |
3,115,000
+375,000
| +14% | +$279K | 0.96% | 25 |
|
|
2022
Q2 | $2.13M | Buy |
2,740,000
+315,000
| +13% | +$245K | 0.96% | 27 |
|
|
2022
Q1 | $2.2M | Buy |
2,425,000
+989,490
| +69% | +$896K | 0.68% | 34 |
|
|
2021
Q4 | $11.5M | Buy |
1,435,510
+11,310
| +0.8% | +$90.6K | 2.44% | 14 |
|
|
2021
Q3 | $11.9M | Buy |
1,424,200
+43,800
| +3% | +$367K | 2.23% | 15 |
|
|
2021
Q2 | $9.3M | Buy |
1,380,400
+77,400
| +6% | +$522K | 1.55% | 21 |
|
|
2021
Q1 | $8.61M | Buy |
+1,303,000
| New | +$8.61M | 1.27% | 22 |
|